This clinical phase I trial had 3 arms: inhibition by fluconazole, inhibition by
ciprofloxacin and placebo. Subjects were treated for 3 days prior to the study day. The
intervention was a single dose of 1 gram metamizole. We took blood samples at set time points
and analysed the concentration of the main metabolites of metamizole at each time point in
plasma.